Effectiveness of Intravitreal Injection of Ranibizumab for Neovascular Age-Related Macular Degeneration with Serous Pigment Epithelial Detachment

about

miRNA-1273g-3p Involvement in Development of Diabetic Retinopathy by Modulating the Autophagy-Lysosome Pathway.

P2860

Q47116645-86C4278F-5665-4E47-8044-59AD61FED210

P2860

Effectiveness of Intravitreal Injection of Ranibizumab for Neovascular Age-Related Macular Degeneration with Serous Pigment Epithelial Detachment

Item

http://www.wikidata.org/entity/Q36691674

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Effectiveness of Intravitreal ...... Pigment Epithelial Detachment

@ast

Effectiveness of Intravitreal ...... Pigment Epithelial Detachment

@en

type

Item

label

Effectiveness of Intravitreal ...... Pigment Epithelial Detachment

@ast

Effectiveness of Intravitreal ...... Pigment Epithelial Detachment

@en

prefLabel

Effectiveness of Intravitreal ...... Pigment Epithelial Detachment

@ast

Effectiveness of Intravitreal ...... Pigment Epithelial Detachment

@en

P1476

Effectiveness of Intravitreal ...... Pigment Epithelial Detachment

@en

P2093

Chun Zhao

http://www.w3.org/2001/XMLSchema#string

Ding Xu

http://www.w3.org/2001/XMLSchema#string

Fang Wang

http://www.w3.org/2001/XMLSchema#string

Lei Chen

http://www.w3.org/2001/XMLSchema#string

Zhen Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

The prevalence of age-related eye diseases and visual impairment in aging: current estimates

Ranibizumab for neovascular age-related macular degeneration

Influence of ranibizumab treatment on the extracellular matrix in patients with neovascular age-related macular degeneration.

Treatment of retinal pigment epithelial detachment with antiangiogenic therapy.

Functional and anatomical outcome of eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab following an exit strategy regimen.

One-year outcome after intravitreal ranibizumab for large, serous pigment epithelial detachment secondary to age-related macular degeneration.

Effectiveness of ranibizumab intravitreal injections for exudative age-related macular degeneration treatment: 12-month outcomes

Ranibizumab: Phase III clinical trial results.

Indocyanine green hyperfluorescence associated with serous retinal pigment epithelial detachment in age-related macular degeneration.

Effect of ranibizumab on serous and vascular pigment epithelial detachments associated with exudative age-related macular degeneration.

P304

833-839

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12659/MSM.895528

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26972376

http://www.w3.org/2001/XMLSchema#string

P932

4793636

http://www.w3.org/2001/XMLSchema#string

Effectiveness of Intravitreal Injection of Ranibizumab for Neovascular Age-Related Macular Degeneration with Serous Pigment Epithelial Detachment

about

P2860

P2860

Effectiveness of Intravitreal Injection of Ranibizumab for Neovascular Age-Related Macular Degeneration with Serous Pigment Epithelial Detachment

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932